151 related articles for article (PubMed ID: 10357835)
1. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.
Groenendijk M; Cantor RM; Blom NH; Rotter JI; de Bruin TW; Dallinga-Thie GM
J Lipid Res; 1999 Jun; 40(6):1036-44. PubMed ID: 10357835
[TBL] [Abstract][Full Text] [Related]
2. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
Dallinga-Thie GM; Bu XD; van Linde-Sibenius Trip M; Rotter JI; Lusis AJ; de Bruin TW
J Lipid Res; 1996 Jan; 37(1):136-47. PubMed ID: 8820109
[TBL] [Abstract][Full Text] [Related]
4. New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.
Groenendijk M; Cantor RM; De Bruin TW; Dallinga-Thie GM
J Lipid Res; 2001 Feb; 42(2):188-94. PubMed ID: 11181747
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
[TBL] [Abstract][Full Text] [Related]
6. Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans.
Song J; Park JW; Park H; Kim JQ
Mol Cells; 1998 Feb; 8(1):12-8. PubMed ID: 9571626
[TBL] [Abstract][Full Text] [Related]
7. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
8. Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.
Groenendijk M; Cantor RM; Funke H; Dallinga-Thie GM
Eur J Clin Invest; 2001 Oct; 31(10):852-9. PubMed ID: 11737222
[TBL] [Abstract][Full Text] [Related]
9. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia.
Groenendijk M; De Bruin TW; Dallinga-Thie GM
Atherosclerosis; 2001 Oct; 158(2):369-76. PubMed ID: 11583715
[TBL] [Abstract][Full Text] [Related]
10. Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia.
Ribalta J; Girona J; Vallvé JC; La Ville AE; Heras M; Masana L
J Lipid Res; 1999 Mar; 40(3):426-31. PubMed ID: 10064730
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.
Tybjaerg-Hansen A; Nordestgaard BG; Gerdes LU; Faergeman O; Humphries SE
Atherosclerosis; 1993 May; 100(2):157-69. PubMed ID: 8102848
[TBL] [Abstract][Full Text] [Related]
12. Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.
Marasco O; Melina F; Mele E; Quaresima B; Zingone A; Focarelli E; Picciotti E; Martelli ML; Fotino L; Vigna MF
Hum Genet; 1993 Mar; 91(2):169-74. PubMed ID: 8096493
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin.
Dallinga-Thie GM; Groenendijk M; Blom RN; De Bruin TW; De Kant E
J Lipid Res; 2001 Sep; 42(9):1450-6. PubMed ID: 11518765
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
[TBL] [Abstract][Full Text] [Related]
15. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia.
Xu CF; Talmud P; Schuster H; Houlston R; Miller G; Humphries S
Clin Genet; 1994 Dec; 46(6):385-97. PubMed ID: 7889654
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.
Paul-Hayase H; Rosseneu M; Robinson D; Van Bervliet JP; Deslypere JP; Humphries SE
Hum Genet; 1992 Feb; 88(4):439-46. PubMed ID: 1740321
[TBL] [Abstract][Full Text] [Related]
17. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Eichenbaum-Voline S; Olivier M; Jones EL; Naoumova RP; Jones B; Gau B; Patel HN; Seed M; Betteridge DJ; Galton DJ; Rubin EM; Scott J; Shoulders CC; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):167-74. PubMed ID: 14551155
[TBL] [Abstract][Full Text] [Related]
18. Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects.
Hong SH; Park WH; Lee CC; Song JH; Kim JQ
Clin Chem; 1997 Jan; 43(1):13-7. PubMed ID: 8990215
[TBL] [Abstract][Full Text] [Related]
19. DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.
Hayden MR; Kirk H; Clark C; Frohlich J; Rabkin S; McLeod R; Hewitt J
Am J Hum Genet; 1987 May; 40(5):421-30. PubMed ID: 2883893
[TBL] [Abstract][Full Text] [Related]
20. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
Xu CF; Angelico F; Del Ben M; Humphries S
Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
